Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy

Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy

Background: CAMP response element binding protein 3-like 1 (CREB3L1) has been indicated as a critical biomarker and can modulate multifaced behaviors of tumor cells in diverse cancers. However, a systematic assessment of CREB3L1 in pan-cancer is of absence, and the predictive value of CREB3L1 in can...

Full description

Bibliographic Details
Main Authors: Zhengjun Lin, Yanlin Wu, XunGang Xiao, Xianghong Zhang, Jia Wan, Tao Zheng, Hongxuan Chen, Tang Liu, Xianzhe Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Genetics
Subjects:
CREB3L1
pan-cancer
prognostic biomarker
tumor immune microenvironment
immunotherapy efficacy
drug sensitivity
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.938510/full

Similar Items

Similar Items